Drug intelligence / Profile preview

Mirgeal Gel

Development stage
Unknown
Lead developer
Pharmextracta
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Mirgeal Gel is an oral dietary supplement formulated to relieve symptoms of gastroesophageal reflux disease (GERD) and non-erosive reflux disease (NERD), such as heartburn, chest pain, and acid regurgitation. Developed by PharmExtracta and distributed in Thailand by Great Eastern Drug, the product is a combination of sodium alginate, licorice root extract (*Glycyrrhiza glabra*), and a standardized bilberry extract (*Vaccinium myrtillus*, specifically Mirtoselect). The sodium alginate forms a physical gel barrier (raft) on top of the gastric contents to mechanically prevent acid reflux. The licorice extract provides anti-inflammatory and anti-ulcer properties, while the bilberry extract promotes cytoprotection and re-epithelialization of the gastric and esophageal mucosa. Mirgeal Gel is administered orally as a gel stick pack.

Brand names
MirgealMirgeal Gel
Other names
sodium alginate + Glycyrrhiza glabra + Vaccinium myrtillussodium alginate + licorice root extract + bilberry extract

Beyond the preview

Go deeper on Mirgeal Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mirgeal Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call